Search results (73)
« Back to NewsThe latest news, stories and exciting findings from across the Oxford cancer research community
2026 Oxford Cancer Immuno-Oncology Network Pump Prime Awards announced
5 Nov, 2026
Congratulations to our 2026 Oxford Cancer Immuno-Oncology Network (OCION) Pump Prime Awardees!
Cancer Research UK Discovery Programme Award for Professor Ignacio Melero
12 Oct, 2026
Congratulations to Professor Ignacio Melero, who has been awarded a Cancer Research UK Discovery Programme Award to investigate how the immune system could be better harnessed to fight cancer.
Oxford tools capture patient experience of cancer immunotherapy
25 Sep, 2026
Immunotherapy has transformed the treatment landscape for many cancers, but understanding its impact requires more than measuring clinical response. The effects of treatment on patients’ quality of life, emotional wellbeing and everyday activities are also important considerations for clinical research and care. Researchers at the University of Oxford have developed two complementary patient-reported outcome measures to capture these experiences in adults receiving immunotherapy for cancer.
Expanding OxCITE: New funding to accelerate immunotherapy research
15 Sep, 2026
New funding from Cancer Research Horizons will help researchers to better understand why some patients respond well to immunotherapy while others do not.
Oxford Cancer Immuno-Oncology Network hosts 2026 Annual Symposium
30 Jun, 2026
The Oxford Cancer Immuno-Oncology Network (OCION) hosted its 2026 Annual Symposium on Friday 19 June 2026 at the Mathematical Institute, University of Oxford.
Researchers uncover hidden mechanism behind a major cancer therapy target
9 Jun, 2026
Kennedy researchers have revealed how one of the immune system's most important regulatory pathways operates at the earliest moments of T cell activation, providing new insights that could help improve cancer immunotherapy.
New personalised therapy targets chronic blood cancer
2 Jun, 2026
A new form of CAR T cell therapy has been designed to find and destroy the cancer-driving cells responsible for a group of blood cancers known as myeloproliferative neoplasms (MPNs), while leaving healthy blood cells unharmed, according to a new study led by UCL and University of Oxford researchers.
Neutrophils in Cancer Networking Event Highlights Emerging Therapeutic Opportunities
15 May, 2026
Researchers, students, and industry representatives recently came together for 'Neutrophils in Cancer', an event organised by Oxford Cancer exploring the growing potential of neutrophil biology in cancer therapy.
Paresh Vyas receives CRUK Discovery Programme Award
11 Mar, 2026
Congratulations to Professor Paresh Vyas in the MRC Weatherall Institute of Molecular Medicine, who has been awarded a Discovery Research grant from Cancer Research UK to investigate cancer immunotherapies.
International Day of Women and Girls in Science: In conversation with Eva Hanlon
13 Feb, 2026
To mark International Day of Women and Girls in Science 2026, we interviewed several of our DPhil in Cancer Science students and alumnae to discuss what motivated them to pursue careers in cancer research. Hear from second-year Medical Undergraduate, Eva Hanlon, who is investigating the interplay between the immune system and tumour evolution in ovarian cancer
International Day of Women and Girls in Science: In conversation with Rebecca Ling
12 Feb, 2026
To mark International Day of Women and Girls in Science 2026, we interviewed several of our DPhil in Cancer Science students and alumnae to discuss what motivated them to pursue careers in cancer research. Hear from alumna Rebecca Ling, now a Clinical Postdoctoral Fellow working in Paediatric Haematology.
International Day of Women and Girls in Science: In conversation with Aglaia Skolariki
11 Feb, 2026
To mark International Day of Women and Girls in Science 2026, we interviewed several of our DPhil in Cancer Science students and alumnae to discuss what motivated them to pursue careers in cancer research. Hear from second-year Clinical Research Training Fellow, Aglaia Skolariki, whose DPhil examines how abnormal cell division in aggressive cancers drives particular genetic changes, and how these changes shape the immune system’s ability to recognise and respond to tumour cells.
Rewiring T cell co-receptors to improve the safety of cancer immunotherapy
19 Jan, 2026
A new study from the Dushek and van der Merwe labs in the Sir William Dunn School of Pathology demonstrates a novel strategy to reduce dangerous off-target effects in engineered T cell therapies.
Professor Sarah Blagden shares cutting-edge precision prevention research at Oxford in new Channel 4 Documentary
21 Nov, 2025
Over the past year, Professor Blagden has been filming for Cancer Detectives: Finding the Cures, a new three-part documentary series from Channel 4 which follows three scientists on the front lines of cancer research across the UK.
Oxford Oncology at ESMO 2025
4 Nov, 2025
The European Society of Medical Oncology (ESMO) Annual Congress took place on 17th-21st October, showcasing the latest advances and insights from the global oncology community. As Europe’s largest oncology meeting, ESMO brings together thousands of researchers, clinicians, and industry leaders for an exchange of cutting-edge research and clinical innovation. Members of the Department of Oncology were in Berlin to present their research, chair sessions, and network with collaborators from across Europe and beyond. Below are some of the highlights from our department’s contributions to ESMO 2025.
Michael Bryan wins international award at Europe’s largest cancer conference
24 Oct, 2025
Michael - who is a CRUK Oxford Centre DPhil in Cancer Science student, working in the Nuffield Department of Medicine's Centre of Immuno-oncology - has been awarded the Best Poster Prize in CNS Tumours at the 2025 European Society for Medical Oncology (ESMO) Congress.
Oxford Cancer Announces 2025 CRIS Cancer Clinical Career Fellows
13 Oct, 2025
Oxford Cancer, together with the CRIS Cancer Foundation, is delighted to announce the appointment of the 2025 CRIS Cancer Postdoctoral Clinical Fellows: Dr Rebecca Ling and Dr Casmir Turnquist. Both Fellows will lead on two distinct projects focused on childhood cancer.
Dr Peter Wan Awarded Pancreatic Cancer UK Fellowship to Develop New Immunotherapy for Pancreatic Cancer
9 Oct, 2025
Dr Peter Kok-Ting Wan, PhD, postdoctoral researcher at the Department of Oncology, has been awarded a prestigious fellowship from Pancreatic Cancer UK to develop a new immunotherapy for pancreatic cancer, which has the lowest survival rate of any common cancer
New ‘off-the-shelf’ immunotherapy shows promise for treating high-risk childhood leukaemia
3 Sep, 2025
Scientists at the University of Oxford, together with colleagues at Imperial College London and the University of Glasgow, have developed a new type of immunotherapy that could improve outcomes for infants and children with high-risk leukaemia.
Action-packed day of immuno-oncology presentations, PPI and networking at this years' annual OCION Symposium!
16 Jun, 2025
On 13th June 2025 we welcomed 180 members of the Oxford Cancer Immuno-Oncology Network to the Mathematical Institute in Oxford for our annual in-person Symposium.